These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6145533)

  • 1. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
    Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
    Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
    Hedberg A; Carlsson E; Fellenius E; Lundgren B
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselectivity of prenalterol and isoproterenol.
    Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
    Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
    Vincent HH; Boomsma F; Man in't Veld AJ; Derkx FH; Wenting GJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1984; 6(1):107-14. PubMed ID: 6199591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B; Hanratty CG; Riddell JG
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
    Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
    Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
    Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
    Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 19. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
    Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.